By Scott Murdoch and Kane Wu
HONG KONG (Reuters) – Chinese medical data group LinkDoc Technology Ltd has shelved its listing in the United States to raise up to $211 million following Beijing’s clampdown on overseas listings, according to three sources with direct knowledge of the matter.
LinkDoc, which is described as a Chinese medical data solutions provider, filed for an initial public offering (IPO) in the United States last month and was due to price its shares after the U.S. market closes Thursday.
The move comes after Beijing on Tuesday said that it would strengthen supervision of all Chinese firms listed offshore, a sweeping regulatory shift that triggered a sell-off in U.S.-listed Chinese stocks.
The sources declined to be named as the information has not yet been made public yet.
Beijing-based LinkDoc did not immediately respond to a request for comment.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.